Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins

Tor C. Savidge, Petri Urvil, Numan Oezguen, Kausar Ali, Aproteem Choudhury, Vinay Acharya, Iryna Pinchuk, Alfredo Torres, Robert D. English, John E. Wiktorowicz, Michael Loeffelholz, Raj Kumar, Lianfa Shi, Weijia Nie, Werner Braun, Bo Herman, Alfred Hausladen, Hanping Feng, Jonathan S. Stamler, Charalabos Pothoulakis

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

The global prevalence of severe Clostridium difficile infection highlights the profound clinical significance of clostridial glucosylating toxins. Virulence is dependent on the autoactivation of a toxin cysteine protease, which is promoted by the allosteric cofactor inositol hexakisphosphate (InsP 6). Host mechanisms that protect against such exotoxins are poorly understood. It is increasingly appreciated that the pleiotropic functions attributed to nitric oxide (NO), including host immunity, are in large part mediated by S-nitrosylation of proteins. Here we show that C. difficile toxins are S-nitrosylated by the infected host and that S-nitrosylation attenuates virulence by inhibiting toxin self-cleavage and cell entry. Notably, InsP 6-and inositol pyrophosphate (InsP 7)-induced conformational changes in the toxin enabled host S-nitrosothiols to transnitrosylate the toxin catalytic cysteine, which forms part of a structurally conserved nitrosylation motif. Moreover, treatment with exogenous InsP 6 enhanced the therapeutic actions of oral S-nitrosothiols in mouse models of C. difficile infection. Allostery in bacterial proteins has thus been successfully exploited in the evolutionary development of nitrosothiol-based innate immunity and may provide an avenue to new therapeutic approaches.

Original languageEnglish (US)
Pages (from-to)1136-1142
Number of pages7
JournalNature Medicine
Volume17
Issue number9
DOIs
StatePublished - Sep 2011

Fingerprint

S-Nitrosothiols
Clostridium difficile
Clostridium Infections
Exotoxins
Clostridium
Phytic Acid
Molecules
Bacterial Proteins
Cysteine Proteases
Virulence
Protein S
Inositol
Cysteine
Nitric Oxide
Innate Immunity
Immunity
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Savidge, T. C., Urvil, P., Oezguen, N., Ali, K., Choudhury, A., Acharya, V., ... Pothoulakis, C. (2011). Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins. Nature Medicine, 17(9), 1136-1142. https://doi.org/10.1038/nm.2405

Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins. / Savidge, Tor C.; Urvil, Petri; Oezguen, Numan; Ali, Kausar; Choudhury, Aproteem; Acharya, Vinay; Pinchuk, Iryna; Torres, Alfredo; English, Robert D.; Wiktorowicz, John E.; Loeffelholz, Michael; Kumar, Raj; Shi, Lianfa; Nie, Weijia; Braun, Werner; Herman, Bo; Hausladen, Alfred; Feng, Hanping; Stamler, Jonathan S.; Pothoulakis, Charalabos.

In: Nature Medicine, Vol. 17, No. 9, 09.2011, p. 1136-1142.

Research output: Contribution to journalArticle

Savidge, TC, Urvil, P, Oezguen, N, Ali, K, Choudhury, A, Acharya, V, Pinchuk, I, Torres, A, English, RD, Wiktorowicz, JE, Loeffelholz, M, Kumar, R, Shi, L, Nie, W, Braun, W, Herman, B, Hausladen, A, Feng, H, Stamler, JS & Pothoulakis, C 2011, 'Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins', Nature Medicine, vol. 17, no. 9, pp. 1136-1142. https://doi.org/10.1038/nm.2405
Savidge TC, Urvil P, Oezguen N, Ali K, Choudhury A, Acharya V et al. Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins. Nature Medicine. 2011 Sep;17(9):1136-1142. https://doi.org/10.1038/nm.2405
Savidge, Tor C. ; Urvil, Petri ; Oezguen, Numan ; Ali, Kausar ; Choudhury, Aproteem ; Acharya, Vinay ; Pinchuk, Iryna ; Torres, Alfredo ; English, Robert D. ; Wiktorowicz, John E. ; Loeffelholz, Michael ; Kumar, Raj ; Shi, Lianfa ; Nie, Weijia ; Braun, Werner ; Herman, Bo ; Hausladen, Alfred ; Feng, Hanping ; Stamler, Jonathan S. ; Pothoulakis, Charalabos. / Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins. In: Nature Medicine. 2011 ; Vol. 17, No. 9. pp. 1136-1142.
@article{8819a31c55ad4d5d8fe04767ec4cc883,
title = "Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins",
abstract = "The global prevalence of severe Clostridium difficile infection highlights the profound clinical significance of clostridial glucosylating toxins. Virulence is dependent on the autoactivation of a toxin cysteine protease, which is promoted by the allosteric cofactor inositol hexakisphosphate (InsP 6). Host mechanisms that protect against such exotoxins are poorly understood. It is increasingly appreciated that the pleiotropic functions attributed to nitric oxide (NO), including host immunity, are in large part mediated by S-nitrosylation of proteins. Here we show that C. difficile toxins are S-nitrosylated by the infected host and that S-nitrosylation attenuates virulence by inhibiting toxin self-cleavage and cell entry. Notably, InsP 6-and inositol pyrophosphate (InsP 7)-induced conformational changes in the toxin enabled host S-nitrosothiols to transnitrosylate the toxin catalytic cysteine, which forms part of a structurally conserved nitrosylation motif. Moreover, treatment with exogenous InsP 6 enhanced the therapeutic actions of oral S-nitrosothiols in mouse models of C. difficile infection. Allostery in bacterial proteins has thus been successfully exploited in the evolutionary development of nitrosothiol-based innate immunity and may provide an avenue to new therapeutic approaches.",
author = "Savidge, {Tor C.} and Petri Urvil and Numan Oezguen and Kausar Ali and Aproteem Choudhury and Vinay Acharya and Iryna Pinchuk and Alfredo Torres and English, {Robert D.} and Wiktorowicz, {John E.} and Michael Loeffelholz and Raj Kumar and Lianfa Shi and Weijia Nie and Werner Braun and Bo Herman and Alfred Hausladen and Hanping Feng and Stamler, {Jonathan S.} and Charalabos Pothoulakis",
year = "2011",
month = "9",
doi = "10.1038/nm.2405",
language = "English (US)",
volume = "17",
pages = "1136--1142",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins

AU - Savidge, Tor C.

AU - Urvil, Petri

AU - Oezguen, Numan

AU - Ali, Kausar

AU - Choudhury, Aproteem

AU - Acharya, Vinay

AU - Pinchuk, Iryna

AU - Torres, Alfredo

AU - English, Robert D.

AU - Wiktorowicz, John E.

AU - Loeffelholz, Michael

AU - Kumar, Raj

AU - Shi, Lianfa

AU - Nie, Weijia

AU - Braun, Werner

AU - Herman, Bo

AU - Hausladen, Alfred

AU - Feng, Hanping

AU - Stamler, Jonathan S.

AU - Pothoulakis, Charalabos

PY - 2011/9

Y1 - 2011/9

N2 - The global prevalence of severe Clostridium difficile infection highlights the profound clinical significance of clostridial glucosylating toxins. Virulence is dependent on the autoactivation of a toxin cysteine protease, which is promoted by the allosteric cofactor inositol hexakisphosphate (InsP 6). Host mechanisms that protect against such exotoxins are poorly understood. It is increasingly appreciated that the pleiotropic functions attributed to nitric oxide (NO), including host immunity, are in large part mediated by S-nitrosylation of proteins. Here we show that C. difficile toxins are S-nitrosylated by the infected host and that S-nitrosylation attenuates virulence by inhibiting toxin self-cleavage and cell entry. Notably, InsP 6-and inositol pyrophosphate (InsP 7)-induced conformational changes in the toxin enabled host S-nitrosothiols to transnitrosylate the toxin catalytic cysteine, which forms part of a structurally conserved nitrosylation motif. Moreover, treatment with exogenous InsP 6 enhanced the therapeutic actions of oral S-nitrosothiols in mouse models of C. difficile infection. Allostery in bacterial proteins has thus been successfully exploited in the evolutionary development of nitrosothiol-based innate immunity and may provide an avenue to new therapeutic approaches.

AB - The global prevalence of severe Clostridium difficile infection highlights the profound clinical significance of clostridial glucosylating toxins. Virulence is dependent on the autoactivation of a toxin cysteine protease, which is promoted by the allosteric cofactor inositol hexakisphosphate (InsP 6). Host mechanisms that protect against such exotoxins are poorly understood. It is increasingly appreciated that the pleiotropic functions attributed to nitric oxide (NO), including host immunity, are in large part mediated by S-nitrosylation of proteins. Here we show that C. difficile toxins are S-nitrosylated by the infected host and that S-nitrosylation attenuates virulence by inhibiting toxin self-cleavage and cell entry. Notably, InsP 6-and inositol pyrophosphate (InsP 7)-induced conformational changes in the toxin enabled host S-nitrosothiols to transnitrosylate the toxin catalytic cysteine, which forms part of a structurally conserved nitrosylation motif. Moreover, treatment with exogenous InsP 6 enhanced the therapeutic actions of oral S-nitrosothiols in mouse models of C. difficile infection. Allostery in bacterial proteins has thus been successfully exploited in the evolutionary development of nitrosothiol-based innate immunity and may provide an avenue to new therapeutic approaches.

UR - http://www.scopus.com/inward/record.url?scp=80052483609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052483609&partnerID=8YFLogxK

U2 - 10.1038/nm.2405

DO - 10.1038/nm.2405

M3 - Article

VL - 17

SP - 1136

EP - 1142

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 9

ER -